A Platform 10 Years and
$100M+ in the Making
Profusa's biologically integrated sensor system redefines what continuous monitoring can achieve — delivering clinical-grade biochemical data from inside the body for up to 9+ months from a single injectable sensor.
Three Components.
One Integrated System.
A novel, biologically compatible hydrogel microsensor injected subcutaneously via standard hypodermic needle. Operates for 9+ months without replacement. Eliminates foreign body rejection — the key barrier for long-duration CGM and oxygen sensors.
9+ months functional life
No surgical removal required
A low-cost, reusable optoelectronic reader worn on the body. Communicates sensor data via Bluetooth to smartphone app and Profusa Cloud. Consumes only an on-body adhesive — dramatically reducing per-patient cost.
Bluetooth connected
iOS & Android compatible
Machine learning algorithms account for individual tissue variation to deliver continuously accurate measurements. NVIDIA technology backbone powers data processing. Planned physician portal links real-time biochemistry to EMR and clinical literature.
Cloud-based
EMR integration roadmap
AI-Adaptive. Personalized. Always Learning.
The Lumee™ platform's machine learning layer sets it apart from any conventional biosensor technology on the market.
The Fundamental Problem We Solved
Every existing biosensor — from CGM devices to pulse oximeters — struggles with one core biological challenge: the body's foreign body response attacks and degrades implanted sensors within days or weeks. Profusa solved this by engineering a hydrogel material that the body treats as its own tissue. The result is a sensor that lives inside the body for 9+ months, continuously transmitting clinical-grade data.